IMvigor210: updated analyses of first-line (1L)...

Annals of Oncology 2016 / 10 Vol. 27; Iss. suppl_6

IMvigor210: updated analyses of first-line (1L) atezolizumab (atezo) in cisplatin (cis)-ineligible locally advanced/metastatic urothelial carcinoma (mUC)

Bellmunt, J., Balar, A., Galsky, M.D., Loriot, Y., Theodore, C., Grande Pulido, E., Castellano, D., Retz, M., Niegisch, G., Bracarda, S., Necchi, A., Vaishampayan, U., Sridhar, S., Eigl, B.J., Hussain
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw373.10
Date:
October, 2016
File:
PDF, 53 KB
english, 2016
Conversion to is in progress
Conversion to is failed